Cancer Drug Discovery Laboratory

About us

This group is headed by A/Prof Larry Wakelin and is focused on topoisomerase I and II poisons (acridinecarboxamides), transcription inhibitors (threading agents), alkylating agents (minor groove binding alkylating agents and intercalating alkylators), and synthetic endonucleases based on metal-bearing acridinecarboxamides.

 

Team